These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
354 related items for PubMed ID: 22000584
1. Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness. Davids M, Richir MC, Visser M, Ellger B, van den Berghe G, van Leeuwen PA, Teerlink T. Metabolism; 2012 Apr; 61(4):482-90. PubMed ID: 22000584 [Abstract] [Full Text] [Related]
2. Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity. Ellger B, Richir MC, van Leeuwen PA, Debaveye Y, Langouche L, Vanhorebeek I, Teerlink T, Van den Berghe G. Endocrinology; 2008 Jun; 149(6):3148-57. PubMed ID: 18292189 [Abstract] [Full Text] [Related]
3. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease. Matsuguma K, Ueda S, Yamagishi S, Matsumoto Y, Kaneyuki U, Shibata R, Fujimura T, Matsuoka H, Kimoto M, Kato S, Imaizumi T, Okuda S. J Am Soc Nephrol; 2006 Aug; 17(8):2176-83. PubMed ID: 16807406 [Abstract] [Full Text] [Related]
4. Liver plays a central role in asymmetric dimethylarginine-mediated organ injury. Ferrigno A, Di Pasqua LG, Berardo C, Richelmi P, Vairetti M. World J Gastroenterol; 2015 May 07; 21(17):5131-7. PubMed ID: 25954086 [Abstract] [Full Text] [Related]
11. The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function. Richir MC, Bouwman RH, Teerlink T, Siroen MP, de Vries TP, van Leeuwen PA. JPEN J Parenter Enteral Nutr; 2008 May 07; 32(6):613-21. PubMed ID: 18974239 [Abstract] [Full Text] [Related]
12. A stable-isotope based technique for the determination of dimethylarginine dimethylaminohydrolase (DDAH) activity in mouse tissue. Maas R, Tan-Andreesen J, Schwedhelm E, Schulze F, Böger RH. J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May 15; 851(1-2):220-8. PubMed ID: 17296339 [Abstract] [Full Text] [Related]
13. Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease. Matsumoto Y, Ueda S, Yamagishi S, Matsuguma K, Shibata R, Fukami K, Matsuoka H, Imaizumi T, Okuda S. J Am Soc Nephrol; 2007 May 15; 18(5):1525-33. PubMed ID: 17409314 [Abstract] [Full Text] [Related]
15. Coordinated regulation of dimethylarginine dimethylaminohydrolase-1 and cationic amino acid transporter-1 by farnesoid X receptor in mouse liver and kidney and its implication in the control of blood levels of asymmetric dimethylarginine. Li J, Wilson A, Gao X, Kuruba R, Liu Y, Poloyac S, Pitt B, Xie W, Li S. J Pharmacol Exp Ther; 2009 Oct 15; 331(1):234-43. PubMed ID: 19605523 [Abstract] [Full Text] [Related]
17. GC-MS assay for hepatic DDAH activity in diabetic and non-diabetic rats by measuring dimethylamine (DMA) formed from asymmetric dimethylarginine (ADMA): evaluation of the importance of S-nitrosothiols as inhibitors of DDAH activity in vitro and in vivo in humans. Chobanyan K, Thum T, Suchy MT, Zhu B, Mitschke A, Gutzki FM, Beckmann B, Stichtenoth DO, Tsikas D. J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct 15; 858(1-2):32-41. PubMed ID: 17825631 [Abstract] [Full Text] [Related]